IDflu (influenza vaccine (split virion, inactivated))
- Region
- 🇪🇺 EU
- Active substance
- influenza vaccine (split virion, inactivated)
- Company
- Sanofi Pasteur S.A.
- Status
- Withdrawn
- Therapeutic area
- Influenza, Human; Immunization
- EU approval
- Tue 24 Feb 2009
- Application
- EMEA/H/C/000966
- ATC
- J07BB02
- Official record
- www.ema.europa.eu
Indication
Prophylaxis of influenza in individuals 60 years of age and over, especially in those who run an increased risk of associated complications.The use of IDflu should be based on official recommendations.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Intanza Withdrawn · Sanofi Pasteur Europe
Follow IDflu
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.